<font color="blue">Is_1</font> <font color="blue">a_1</font> <font color="blue">2-week_1</font> <font color="blue">duration_1</font> <font color="blue">sufficient_1</font> <font color="blue">for_1</font> <font color="blue">stenting_1</font> <font color="blue">in_1</font> <font color="blue">endopyelotomy_1</font> <font color="blue">?_1</font> 
<br>
<br> PURPOSE Internal stenting is an integral part of endopyelotomy . Studies in animals show good healing after 1 to 2 weeks of ureterotomy . Inherent stent related problems warrant a minimum possible duration of stenting without compromising the results of endopyelotomy . We performed a prospective randomized trial <font color="blue">to_1</font> <font color="blue">evaluate_1</font> <font color="blue">the_1</font> <font color="blue">optimum_2</font> <font color="blue">duration_2</font> <font color="blue">of_2</font> <font color="blue">stenting_2</font> <font color="blue">after_2</font> <font color="blue">endopyelotomy_2</font> <font color="blue">._2</font> 
<br> MATERIALS AND METHODS A total of 57 consecutive patients with primary ureteropelvic junction obstruction were randomized to undergo 7/14Fr internal endopyelotomy stent placement for 2 ( group 1 ) and 4 ( group 2 ) weeks . <font color="blue">A_1</font> <font color="blue">symptom_2</font> <font color="blue">based_2</font> <font color="blue">questionnaire_2</font> was administered to all patients at stent removal . Followup was done with <font color="blue">diuretic_1</font> <font color="blue">scanning_1</font> <font color="blue">at_1</font> <font color="blue">3_1</font> <font color="blue">,_1</font> <font color="blue">6_1</font> <font color="blue">,_1</font> <font color="blue">9_1</font> <font color="blue">and_1</font> <font color="blue">12_1</font> <font color="blue">months_1</font> <font color="blue">and_1</font> <font color="blue">then_1</font> <font color="blue">yearly_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">thereafter_1</font> <font color="blue">with_1</font> <font color="blue">diuretic_1</font> <font color="blue">renography_1</font> <font color="blue">._1</font> 
<br> RESULTS In each group 26 patients were available for evaluation . The 2 groups were comparable in terms of <font color="blue">age_1</font> <font color="blue">,_1</font> <font color="blue">sex_1</font> <font color="blue">,_1</font> <font color="blue">symptoms_1</font> <font color="blue">and_1</font> <font color="blue">ipsilateral_1</font> <font color="blue">glomerular_1</font> <font color="blue">filtration_1</font> <font color="blue">rate_1</font> <font color="blue">._1</font> Mean followup was 22.3 ( range 12 to 36 ) and 21.3 months ( range 12 to 35 ) in groups 1 and 2 , respectively . At the end of 1 year 24 group 1 ( 92.3% ) and 23 group 2 ( 90.3% ) patients had an <font color="blue">improved_1</font> <font color="blue">drainage_2</font> <font color="blue">pattern_2</font> <font color="blue">._2</font> <font color="blue">This_1</font> <font color="blue">difference_1</font> <font color="blue">was_1</font> <font color="blue">not_1</font> <font color="blue">significant_1</font> <font color="blue">._1</font> <font color="blue">Stent_1</font> <font color="blue">related_1</font> <font color="blue">symptoms_1</font> <font color="blue">were_1</font> <font color="blue">present_1</font> <font color="blue">in_1</font> <font color="blue">a_1</font> <font color="blue">good_1</font> <font color="blue">proportion_1</font> <font color="blue">of_1</font> <font color="blue">patients_1</font> <font color="blue">in_1</font> <font color="blue">groups_1</font> <font color="blue">1_1</font> <font color="blue">and_1</font> <font color="blue">2_1</font> <font color="blue">but_1</font> <font color="blue">there_1</font> <font color="blue">was_1</font> <font color="blue">a_1</font> <font color="blue">significant_1</font> <font color="blue">difference_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">incidence_2</font> <font color="blue">of_2</font> <font color="blue">urinary_2</font> <font color="blue">tract_2</font> <font color="blue">infections_2</font> <font color="blue">(_2</font> <font color="blue">11.5%_2</font> <font color="blue">versus_2</font> <font color="blue">38.1%_2</font> <font color="blue">,_2</font> <font color="blue">p_2</font> <font color="blue">=_2</font> <font color="blue">0.04_2</font> <font color="blue">)_2</font> <font color="blue">._2</font> <font color="blue">Of_1</font> <font color="blue">the_1</font> <font color="blue">group_1</font> <font color="blue">2_1</font> <font color="blue">patients_1</font> <font color="blue">64%_1</font> <font color="blue">preferred_1</font> <font color="blue">2_1</font> <font color="blue">weeks_1</font> <font color="blue">of_1</font> <font color="blue">stenting_1</font> <font color="blue">._1</font> 
<br> CONCLUSIONS <font color="blue">Two_1</font> <font color="blue">weeks_1</font> <font color="blue">seems_1</font> <font color="blue">to_1</font> <font color="blue">be_1</font> <font color="blue">a_1</font> <font color="blue">sufficient_1</font> <font color="blue">duration_1</font> <font color="blue">to_1</font> <font color="blue">allow_1</font> <font color="blue">functional_1</font> <font color="blue">restoration_1</font> <font color="blue">across_1</font> <font color="blue">the_1</font> <font color="blue">ureteropelvic_1</font> <font color="blue">junction_1</font> <font color="blue">after_1</font> <font color="blue">endopyelotomy_1</font> <font color="blue">and_1</font> <font color="blue">decrease_1</font> <font color="blue">stent_1</font> <font color="blue">related_1</font> <font color="blue">complications_1</font> <font color="blue">._1</font> <font color="blue">
<br>
<br>_1</font>